98 related articles for article (PubMed ID: 7539175)
1. Clinical manifestations of benign prostatic hyperplasia.
Madsen FA; Bruskewitz RC
Urol Clin North Am; 1995 May; 22(2):291-8. PubMed ID: 7539175
[TBL] [Abstract][Full Text] [Related]
2. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
Hohenfellner M; Thüroff JW
Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
[TBL] [Abstract][Full Text] [Related]
3. [New developments in the diagnosis of benign prostatic hyperplasia].
Vaida M; Novac B; Gheorghiu V; Novac C
Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):88-96. PubMed ID: 19292085
[TBL] [Abstract][Full Text] [Related]
4. Benign prostatic hyperplasia: use of drug therapy in primary care.
Beduschi R; Beduschi MC; Oesterling JE
Geriatrics; 1998 Mar; 53(3):24-8, 33-4, 37-40. PubMed ID: 9511773
[TBL] [Abstract][Full Text] [Related]
5. Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement.
Porru D; Scarpa RM; Prezioso D; Bertaccini A; Rizzi CA;
Prostate Cancer Prostatic Dis; 2005; 8(1):45-9. PubMed ID: 15655566
[TBL] [Abstract][Full Text] [Related]
6. Benign prostatic hyperplasia: clinical manifestations and evaluation.
Santos Dias J
Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
[TBL] [Abstract][Full Text] [Related]
7. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).
Madersbacher S; Alivizatos G; Nordling J; Sanz CR; Emberton M; de la Rosette JJ
Eur Urol; 2004 Nov; 46(5):547-54. PubMed ID: 15474261
[TBL] [Abstract][Full Text] [Related]
8. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
Kaplan SA; Olsson CA; Te AE
J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
[TBL] [Abstract][Full Text] [Related]
9. Managing patients with benign prostatic hyperplasia.
Hicks RJ; Cook JB
Am Fam Physician; 1995 Jul; 52(1):135-42, 145-6. PubMed ID: 7541601
[TBL] [Abstract][Full Text] [Related]
10. Outline of JUA clinical guidelines for benign prostatic hyperplasia.
Homma Y; Gotoh M; Yokoyama O; Masumori N; Kawauchi A; Yamanishi T; Ishizuka O; Seki N; Kamoto T; Nagai A; Ozono S;
Int J Urol; 2011 Nov; 18(11):741-56. PubMed ID: 22050351
[TBL] [Abstract][Full Text] [Related]
11. Canadian guidelines for the management of benign prostatic hyperplasia.
Nickel JC; Herschorn S; Corcos J; Donnelly B; Drover D; Elhilali M; Goldenberg L; Grantmyre J; Laroche B; Norman R; Piercy B; Psooy K; Steinhoff G; Trachtenberg J; Saad F; Tanguay S; ;
Can J Urol; 2005 Jun; 12(3):2677-83. PubMed ID: 16011814
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
13. Benign prostatic hyperplasia: treat or wait?
Davidson JH; Chutka DS
J Fam Pract; 2008 Jul; 57(7):454-63. PubMed ID: 18625168
[TBL] [Abstract][Full Text] [Related]
14. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
15. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
Fourcade RO; Théret N; Taïeb C;
BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
[TBL] [Abstract][Full Text] [Related]
16. [Benign prostatic hyperplasia. Guidelines and recommendations in urological clinical practice].
Silva MM; Sousa RC
Acta Med Port; 1999; 12(1-3):103-11. PubMed ID: 10423883
[TBL] [Abstract][Full Text] [Related]
17. Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer.
Romppanen J; Haapalainen T; Punnonen K; Penttilä I
Anticancer Res; 2002; 22(1A):415-20. PubMed ID: 12017325
[TBL] [Abstract][Full Text] [Related]
18. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
Fawzy A; Fontenot C; Guthrie R; Baudier MM
Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
[TBL] [Abstract][Full Text] [Related]
19. [Benign hyperplasia of the prostate--a known and unknown disease].
Safarík L; Dvorácek J
Cas Lek Cesk; 2001 Nov; 140(23):717-22. PubMed ID: 11787233
[TBL] [Abstract][Full Text] [Related]
20. [Serum and urine prostate-specific antigen ratio: its value in the distinction between prostate cancer and adenoma when serum prostate-specific antigen level is between 4 and 10 ng/ml].
Irani J; Millet C; Levillain P; Doré B; Bégon F; Aubert J
Chirurgie; 1997; 122(8-9):478-82. PubMed ID: 9616891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
